Zantac’s Link to Cancer Hidden For Decades

Medications for heartburn, acid reflux, and ulcers were the very first billion-dollar blockbusters back in the 1980’s. For a while, Zantac was the top prescription medication of all time. What have we learned about strong financial incentives and predatory pharma behavior? Profits are always prioritized over safety. In the case of Zantac, ongoing lawsuits claim that cancer risks were intentionally hidden for nearly four decades.

Lawsuits have revealed internal documents at Glaxo outlining how Zantac (ranitidine) is an inherently unstable molecule, easily degrading with heat, humidity, or mere time into NDMA.

NDMA is so potent at causing cancer, it is literally given to lab animals for cancer research.

This medication was one of the first to break the billion dollar a year ceiling, and it was taken by tens of millions of Americans prior to being pulled off the market in 2020.

Despite Zantac’s shocking fall from grace, a recent billion-dollar lawsuit settlement, and the ghoulish cover-up of the cancer risk, the mainstream media is completely silent on this story.

The Zantac situation has become the latest example in our ongoing coverage of the “pharma playbook,” with many important patterns for the Nurses Out Loud audience to recognize:
● Pharma executives will lie for profit even if it means killing masses of people
● Federal regulators are some combination of incompetent and complicit with the predatory behavior
● Often, the lawsuit isn’t actual justice, it’s part of the cover-up
● The mainstream media is willing to be silent on what should be headline news
● The fraud, profiteering, lies, and damage being done by our modern healthcare system is a problem going back many decades

For more information about the Nurses, go to NursesOutLoud.com
Be Sure to visit our sponsor: Functional Nurse Academy